Danny regularly tries cases and arbitrations in Tennessee, Arkansas and Mississippi. He has tried an arbitration or case in 16 states and three foreign countries. He is known as a practical problem solver who has a keen sense of a client’s ultimate business objective and keeps that in focus throughout the life of the case.

The post Daniel W. Van Horn appeared first on The BTI Consulting Group.

Richard leads a team of 18 lawyers in several offices of the firm who have worked closely with him in successfully handling MDLs and other litigation with a national scope. Together, with the assistance of numerous other attorneys throughout Nelson Mullins’ nationwide platform, the team has successfully litigated and resolved thousands of cases around the country.

The post Richard B. North, Jr. appeared first on The BTI Consulting Group.

Nationally recognized for her extraordinary trial record of 58 defense verdicts, Lori leads a global practice that focuses on complex litigation of all types including products liability and pharmaceutical, medical device, and health care litigation. Lori has served as national, regional, and trial counsel for numerous medical device and pharmaceutical manufacturers, handling all types of litigation, including class actions, multidistrict litigation, and trials nationally. Lori and her team routinely take complex cases to trial and win, including some of the most complex mass torts in history. Well known for her ability to win high-stakes trials, Lori is often called upon to “parachute in” at the last minute before trial, especially in challenging cases in dangerous jurisdictions. Lori is Board Certified in Complex Litigation by the National Board of Trial Advocacy.

The post Lori G. Cohen appeared first on The BTI Consulting Group.

Mr. Cerrito has represented and continues to represent the patentees for Revlimid, a product approved for the treatment of Multiple Myeloma, which has annual revenues in excess of $8 billion dollars. He is also lead counsel for the patentee in Hatch-Waxman cases relating to Abraxane®, Xyrem®, and Pomalyst® among others. Nick’s past representations have also included Namenda®, Altace®, Avinza® Oxycontin®, Moexipril®, Skelaxin®, Cardizem®, Sonata®, Itsodax®, Qysima® and Thalomid®. As co-lead trial counsel, he successfully represented the only defendant to prevail in the first-wave Prilosec® litigation, at that time the largest pharmaceutical litigation ever.

The post F. Dominic Cerrito appeared first on The BTI Consulting Group.

The post Hildy Sastre appeared first on The BTI Consulting Group.

The post Jon Strongman appeared first on The BTI Consulting Group.

Stephen also regularly counsels clients on a wide-range of regulatory, risk management, due-diligence, product labeling, policy and crisis-management issues.

The post Stephen C. Matthews appeared first on The BTI Consulting Group.

Mr. Johnston has served as co-lead _trial counsel in multiple pharmaceutical products liability trials, including Hogan v. Novartis Pharm. Corp., No. 1-06-CV-00260-BMC (E.D.N.Y. 2011), which _resulted in a defense verdict for our client. He manages the defense of class action, consolidated, and serial litigations and represents _clients in significant individual matters as well. He has developed key liability defenses to sweeping allegations of corporate _misconduct, and he has worked with experts and senior company employees to advance those _defenses in depositions and at trial. He defends depositions of corporate employees and has been involved in motions disputing the admissibility at trial of videotaped corporate depositions. He prepared eight corporate witnesses to testify at trial in Meng v. Novartis Pharm. Corp., No. MID-L-7670-07-MT (N.J. Super. Ct. Law Div. May 15, 2013) in New Jersey, and in Davids v. Novartis Pharm. Corp., No. 06-CV-431 (E.D.N.Y.2012) in New York federal court (where he served as co-lead trial counsel). Mr. Johnston has developed and presented the testimony of scientific experts and cross-examined plaintiffs’ experts both at deposition and trial. In support of his work developing liability defenses, he is co-leader of the Firm’s e-Discovery group. He has experience implementing court-approved document review strategies and stays current on developments regarding Technology Assisted Review and other emerging document review protocols. He has supervised productions numbering in the tens of millions of pages of documents and regularly counsels clients regarding e-Discovery issues. He is a member of The Sedona Conference.

The post Robert E. Johnston appeared first on The BTI Consulting Group.

The post Jeffrey L. Handwerker appeared first on The BTI Consulting Group.

Greg is a committed believer in Justice Learned Hand’s maxim, “Thou shalt not ration justice.” As the immediate past pro bono coordinator for the Chicago office, Greg strives to lead by example. He has represented dozens of indigent clients in cases involving discrimination, victim advocacy, prisoner rights, and civil rights, and has written and filed amicus briefs on behalf of dozens of major bar associations and public interest organizations in the U.S. Supreme Court, numerous federal appeals courts, and state courts around the country. His efforts as pro bono coordinator fostered a culture of commitment to service, and succeeded in elevating the office’s pro bono hours by several multiples during his nine-year tenure. As co-chair of the litigation practice, Greg has also been instrumental in promoting and applying standards of diversity and inclusion in hiring, retention, and promotion.

The post Gregory E. Ostfeld appeared first on The BTI Consulting Group.